AgomAb Therapeutics NV American Depositary Shares (AGMB) — Net Asset Quality Index
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Net Asset Quality Index of 88.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $165.63 Million minus total liabilities of $18.70 Million yields net assets of $146.93 Million. A higher index indicates a stronger, lower-leverage balance sheet. See AGMB days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
AgomAb Therapeutics NV American Depositary Shares Net Asset Quality Index Over Time (2021–2025)
This chart shows how AgomAb Therapeutics NV American Depositary Shares's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 88.7%, representing net assets of $146.93 Million against total assets of $165.63 Million USD. Explore AgomAb Therapeutics NV American Deposita (AGMB) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for AgomAb Therapeutics NV American Depositary Shares (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see AgomAb Therapeutics NV American Deposita market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.2% | $130.90 Million | $153.71 Million | $22.80 Million | ▼ -6.0 pp |
| 2024 | 91.1% | $188.08 Million | $206.36 Million | $18.28 Million | ▲ +2.7 pp |
| 2023 | 88.4% | $151.44 Million | $171.26 Million | $19.82 Million | ▲ +22.8 pp |
| 2022 | 65.6% | $66.25 Million | $101.00 Million | $34.75 Million | ▲ +15.2 pp |
| 2021 | 50.4% | $42.36 Million | $84.00 Million | $41.63 Million | — |